Experts seek painkiller ban

Last updated 05:00 14/02/2013

Relevant offers


Multiple sclerosis battler Kane Roper fights for $200,000 treatment Minister welcomes NZ's first three way kidney exchange Hutt Valley teens' lengthy wait times for mental health services Stacey Kirk: Grim prospects for suicide, as conversation goes quiet What matters most to girls: New research boosts Girl Guide biscuit drive Thousands of Kiwi kids waiting for mental health treatment Hundreds get cheap tattoos for suicide awareness in Christchurch Sir Colin Meads weighs in on NZ's 'harden up' mentality amid battle against cancer 94-year-old Wellington woman waits three months for caregiver after displacing hip Kapiti blamed for missing Otaki health votes

A popular painkiller should be banned worldwide because it raises the risk of heart attack and stroke by almost half, British academics say.

Risks from diclofenac, widely sold as Voltaren, were highest in those who used it regularly, and safer options were available, they said.

Medsafe in New Zealand said it would consider the research, but noted previous reviews had shown its benefits outweighed potential risks.

Diclofenac is a non-steroidal anti-inflammatory drug often prescribed after surgery or to combat arthritic pain when other painkillers are not strong enough.

It has been available in New Zealand for more than 20 years. I

t is subsidised by state drug-buying agency Pharmac, with 375,000 people being prescribed it in the year ending November 2012. That figure does not include those who buy it over the counter.

Ad Feedback

- The Dominion Post

Special offers
Opinion poll

Should fluoride in water be the responsibility of central government?



Vote Result

Featured Promotions

Sponsored Content